Project Grant R01CA315474
Award Date 6/19/26
Completion Date 5/31/31
Dollars Obligated $656K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
St. Louis, MO 63110, USA
Similar Awards
- Federal Grant Award Summary The National Cancer Institute (NCI) awarded The Children's Hospital of Philadelphia $749,133 under the Cancer Cause and Prevention Research program (CFDA 93.393) for a Project Grant beginning June 1, 2026, through May 31, 2031. The award funds development and evaluation of DECIDES 2.0 (AYA Deciding About Cancer Clinical Intervention: Decision Aid for Education and Support), an enhanced interactive mobile-friendly web-based decision support tool designed to improve...
- Federal Project Grant Award Summary The National Cancer Institute (NCI) awarded The Washington University a $425,088 Project Grant effective May 1, 2026, through April 30, 2031, under the Cancer Cause and Prevention Research program (CFDA 93.393). This research initiative will deliver a comprehensive evaluation of lung cancer care quality and treatment outcomes for Medicare-eligible older adults, comparing delivery patterns and clinical outcomes between Traditional Medicare (fee-for-service) and...
- Federal Grant Award Summary The National Cancer Institute (NCI) awarded The Regents of the University of Colorado a $656,046 Project Grant on August 1, 2025, under the Cancer Cause and Prevention Research program (CFDA 93.393) to conduct a randomized controlled trial of EASE (Exposure-based Anxiety and Symptom Elimination), a novel behavioral intervention designed to reduce fear of cancer progression (FOP) and cancer-related trauma symptoms in adults with advanced cancer. The five-year...
- Federal Grant Award Summary The National Cancer Institute awarded a $731,503 Project Grant to Sloan-Kettering Institute for Cancer Research, effective June 1, 2026 through May 31, 2031, under the Cancer Cause and Prevention Research program (CFDA 93.393). The award funds a randomized controlled trial (RCT) evaluating Brief Behavioral Activation for Older Adult Cancer Survivors (BBA-OACS), a telehealth-based psychotherapy intervention designed to address clinically significant depression among...
- Federal Grant Award Summary The National Cancer Institute (NCI) awarded a Project Grant totaling $203,542.00 to The Washington University, Office of Sponsored Research Services, effective July 1, 2025, through June 30, 2027, under the Cancer Research Manpower program (CFDA 93.398). This award supports a two-year research initiative investigating the impact of clonal hematopoiesis (CH)—specifically TET2-mutant hematopoietic cells—on solid tumor development and therapeutic response. The research...
- Federal Grant Award Summary The National Cancer Institute (NCI) awarded The Washington University a Project Grant totaling $645,185 under the Cancer Treatment Research program (CFDA 93.395) on May 15, 2026, with completion targeted for April 30, 2031. This research initiative, titled "Expand and Pull: Long-Acting IL-7 and Oncolytic Virus to Treat Glioblastoma," will develop and evaluate a novel combination immunotherapy approach for glioblastoma, an aggressive brain tumor with a median...
- Federal Project Grant Award Summary The National Cancer Institute (NCI) awarded Ann & Robert H Lurie Children's Hospital of Chicago a $651,859 Project Grant on September 19, 2025, under the Cancer Cause and Prevention Research program (CFDA 93.393) to develop and evaluate #AYAOSM (The AYA Oncology Self-Care Movement), an influencer-driven social media intervention designed to improve oral chemotherapy adherence in adolescents and young adults (AYAs) with acute lymphoblastic leukemia. Prior...
- Federal Project Grant Award Summary The National Cancer Institute (NCI) awarded The Johns Hopkins University a $105,076 Project Grant under the Cancer Research Manpower program (CFDA 93.398) effective February 15, 2026, with a completion date of August 14, 2027. This award funds a multi-method research investigation examining electronic communication (e-communication) between pediatric cancer caregivers and healthcare teams. The study will analyze the frequency, modes, and quality of...
- Federal Project Grant Award Summary The National Cancer Institute awarded The MGH Institute of Health Professions, Inc. a $696,498 Project Grant (CFDA 93.393 - Cancer Cause and Prevention Research) effective May 1, 2026, through April 30, 2031, to develop and optimize a multicomponent intervention designed to improve functional recovery and quality of life among breast cancer survivors. The research employs the Multiphase Optimization Strategy (MOST) framework to systematically evaluate three...
- Federal Project Grant Award Summary The National Cancer Institute awarded The Washington University in St. Louis a $399,829 Project Grant effective May 13, 2026, through April 30, 2028, under the Cancer Treatment Research program (CFDA 93.395). The award supports research and development of a novel dendritic cell (DC)-based immunotherapy designated AB7H3-TLR4 CAR-DCs. This therapeutic approach involves engineering dendritic cells to express a B7H3-specific chimeric antigen receptor (CAR) fused...